Filtros de búsqueda

Lista de obras de Cristina Teixidó

AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas

artículo científico publicado en 2015

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

artículo científico publicado en 2015

Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements

artículo científico publicado en 2014

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

artículo científico publicado en 2017

Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines

artículo científico publicado en 2013

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines ⬇️

artículo científico publicado el 3 de abril de 2012

ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.

artículo científico publicado en 2013

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

artículo científico publicado en 2018

Impact of the new EGF receptor and ALK testing guideline on personalized lung cancer medicine.

artículo científico publicado en 2013

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

artículo científico publicado en 2018

Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer

artículo científico publicado en 2020

PD-L1 expression testing in non-small cell lung cancer.

artículo científico publicado en 2018

Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients

artículo científico publicado en 2020

Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform

artículo científico publicado en 2019

RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants

artículo científico publicado en 2018

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

artículo científico publicado en 2015

RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence.

artículo científico publicado en 2011

TAZ is highly expressed in gastric signet ring cell carcinoma

artículo científico publicado en 2014

Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients

scientific article published on 30 April 2020

Using biomarkers to determine optimal combinations with immunotherapy (biomarker discovery perspective)

scientific article published on 14 May 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda